Dow Up0.07% Nasdaq Up0.61%

Prudential Jennison Health Sciences A (PHLAX)

52.89 Up 0.61(1.17%) Nov 26

Profile as of Oct 30, 2014Get Profile for:
Prudential Jennison Health Sciences A
Prudential Sector Funds IncGateway Center Three 100 Mulberry StreetNewark, NJ 07102
Phone: 800-225-1852
Fund Overview 
Fund Family:Prudential Investments
Net Assets:2.82B
Year-to-Date Return:26.50%
Morningstar Rating:4 stars
Fund Inception Date:Jun 30, 1999
Morningstar Style Box 
[View Category Definition]
View Top Health Funds
About the Morningstar Style Box
Management Information 
David A. Chan
Lead Manager since Jun 30, 1999
Managing director and portfolio manager of Jennison Associates LLC since 1999. He has a BA from Harvard University and an MBA from Columbia University. Mr. Chan generally has final authority over all aspects of the portfolio’s investments, including but not limited to, purchases and sales of individual securities, portfolio construction, risk assessment, and management of cash flows.
Investment Information 
Min Initial Investment:2,500
Min Initial Investment, IRA:1,000
Min Initial Investment, AIP:50
Min Subsequent Investment:100
Min Subsequent Investment, IRA:100
Min Subsequent Investment, AIP:50
PHLAX can be purchased from 110 brokerages.

Fund Summary 
The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector. It will invest in securities of issuers among a number of different countries throughout the world, one of which may be the United States. The portfolio managers use fundamental and quantitative analyses to select individual securities, and they may invest more than 5% of the fund's assets in any one issuer. The fund participates in the initial public offering (IPO) market. It is non-diversified.

Fund Operations 
Last Dividend : 0.00
Last Cap Gain (Dec 16, 2013) : 0.00
Annual Holdings Turnover (Nov 24, 2014) : 54.00%
Average for Category:53.85%
Fees & Expenses 
ExpensePHLAXCategory Avg
Annual Report Expense Ratio (net):1.18%1.43%
Prospectus Net Expense Ratio:1.18%N/A
Prospectus Gross Expense Ratio:1.18%N/A
Max 12b1 Fee:0.30%N/A
Max Front End Sales Load:5.50%5.28%
Max Deferred Sales Load: N/A2.37%
3 Yr Expense Projection*:904667
5 Yr Expense Projection*:1,1631,042
10 Yr Expense Projection*:1,9032,038
* Per $10,000 invested